Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
Actual shortage: | 55 (12%) | |
Anticipated shortage: | 14 (3%) | |
Avoided shortage: | 8 (2%) | |
Resolved: | 368 (83%) | |
Discontinuation Reports |
68 |
|
To be discontinued: | 7 (10%) | |
Discontinued: | 51 (75%) | |
Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
13 (17%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
SOLIFENACIN | 5MG | TABLET | Actual shortage | 2024-01-30 | 2024-05-01 | 217809 |
MYCOPHENOLATE MOFETIL | 500MG | TABLET | Resolved | 2024-01-30 | 2024-02-13 | 217798 |
LEVETIRACETAM | 250MG | TABLET | Resolved | 2024-01-30 | 2024-03-02 | 217793 |
CANDESARTAN | 8MG | TABLET | Resolved | 2024-01-30 | 2024-04-23 | 217790 |
SERTRALINE | 50MG | CAPSULE | Actual shortage | 2024-01-30 | 2024-03-27 | 217783 |
GABAPENTIN | 100MG | CAPSULE | Resolved | 2024-01-30 | 2024-03-14 | 217766 |
TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-17 | 2024-02-29 | 216290 |
RABEPRAZOLE EC | 20MG | TABLET (ENTERIC-COATED) | Actual shortage | 2024-01-17 | 2024-01-30 | 216283 |
LEVETIRACETAM | 500MG | TABLET | Resolved | 2024-01-17 | 2024-04-11 | 216276 |
CANDESARTAN | 16MG | TABLET | Actual shortage | 2024-01-17 | 2024-03-07 | 216273 |
SERTRALINE | 50MG | CAPSULE | Actual shortage | 2024-01-17 | 2024-01-30 | 216267 |
SERTRALINE | 25MG | CAPSULE | Actual shortage | 2024-01-17 | 2024-01-30 | 216264 |
SERTRALINE | 100MG | CAPSULE | Resolved | 2024-01-17 | 2024-02-13 | 216259 |
SERTRALINE | 100MG | CAPSULE | Actual shortage | 2024-01-17 | 2024-05-01 | 216254 |
PERINDOPRIL ERBUMINE | 8MG | TABLET | Resolved | 2024-01-17 | 2024-02-15 | 216247 |
RABEPRAZOLE EC | 10MG | TABLET (ENTERIC-COATED) | Actual shortage | 2023-12-26 | 2024-05-01 | 214284 |
BACLOFEN | 10MG | TABLET | Avoided shortage | 2023-12-01 | 2023-12-01 | 212107 |
CIPROFLOXACIN | 500MG | TABLET | Actual shortage | 2023-11-22 | 2024-05-03 | 211200 |
CIPROFLOXACIN | 250MG | TABLET | Actual shortage | 2023-11-22 | 2024-04-29 | 211197 |
TRAZODONE | 150MG | TABLET | Resolved | 2023-11-22 | 2023-12-26 | 211117 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |
DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |
BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-12-16 | 2021-12-17 | 151293 |
TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
TERAZOSIN | 1MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151278 |
TERAZOSIN | 10MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151275 |
ALPRAZOLAM | 0.50MG | TABLET | Discontinued | 2021-08-12 | 2021-08-12 | 144041 |
ALPRAZOLAM | 0.50MG | TABLET | Discontinued | 2021-08-12 | 2021-12-17 | 144038 |
ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144035 |
LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144029 |
LORAZEPAM | 1.0MG | TABLET | Discontinued | 2021-05-17 | 2021-11-16 | 139511 |
OXYCODONE/ACET | 5MG 325MG | TABLET | Discontinued | 2020-04-08 | 2020-06-09 | 111531 |
OXYCODONE/ACET | 5MG 325MG | TABLET | Discontinued | 2020-04-08 | 2020-06-09 | 111527 |
TRAMADOL/ACET | 325MG 37.5MG | TABLET | Discontinued | 2020-04-08 | 2020-07-07 | 111524 |
MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |